![]() | Up a level |
Al Hamed, Rama; Labopin, Myriam; Wu, Depei; Gedde-Dahl, Tobias; Aljurf, Mahmoud; Forcade, Edouard; Salmenniemi, Urpu; Passweg, Jakob; Maertens, Johan; Pabst, Thomas; Versluis, Jurjen; Itäla-Remes, Maija; Huang, Xiao-Jun; Van Gorkom, Gwendolyn; Schroeder, Thomas; Sanz, Jaime; Blaise, Didier; Reményi, Péter; Schanz, Urs; Esteve, Jordi; ... (2024). Allogeneic stem cell transplantation in de novo core-binding factor acute myeloid leukemia in first complete remission: data from the EBMT. (In Press). Bone marrow transplantation Springer Nature 10.1038/s41409-024-02373-5
Codilupi, Tamara; Szybinski, Jakub; Arunasalam, Stefanie; Jungius, Sarah; Dunbar, Andrew C; Stivala, Simona; Brkic, Sime; Albrecht, Camille; Vokalova, Lenka; Yang, Julie L; Buczak, Katarzyna; Ghosh, Nilabh; Passweg, Jakob R; Rovo, Alicia; Angelillo-Scherrer, Anne; Pankov, Dmitry; Dirnhofer, Stephan; Levine, Ross L; Koche, Richard and Meyer, Sara C (2024). Development of resistance to type II JAK2 inhibitors in MPN depends on AXL kinase and is targetable. Clinical cancer research, 30(3), pp. 586-599. American Association for Cancer Research 10.1158/1078-0432.CCR-23-0163
Ngai, Lok Lam; Hanekamp, Diana; Janssen, Fleur; Carbaat-Ham, Jannemieke; Hofland, Maaike A M; Fayed, Mona M H E; Kelder, Angèle; Oudshoorn-van Marsbergen, Laura; Scholten, Willemijn J; Snel, Alexander N; Bachas, Costa; Tettero, Jesse M; Breems, Dimitri A; Fischer, Thomas; Gjertsen, Bjorn T; Griskevicius, Laimonas; Juliusson, Gunnar; van de Loosdrecht, Arjan A; Maertens, Johan A; Manz, Markus G; ... (2023). Prospective Validation of the Prognostic Relevance of CD34+CD38- AML Stem Cell frequency in the HOVON-SAKK132 trial. Blood, 141(21), pp. 2657-2661. American Society of Hematology 10.1182/blood.2022019160
Adam, Franziska C; Szybinski, Jakub; Halter, Jörg P; Cantoni, Nathan; Wenzel, Friedel; Leonards, Katharina; Brkic, Sime; Passweg, Jakob R; Touw, Ivo; Maxson, Julia E; Meyer, Sara C (2022). Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia. Current oncology, 29(2), pp. 805-815. MDPI 10.3390/curroncol29020068